Congress Weighs Repeal of Tax Credit for Rare Disease Drugs

Long untouchable, the incentive for development of orphan drugs is now a Republican target as lawmakers consider a broad tax overhaul.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Drugs (Pharmaceuticals) Federal Taxes (US) Corporate Taxes Tax Credits, Deductions and Exemptions Biotechnology and Bioengineering House of Representatives Senate Medicine and Health United States Politics and Government Source Type: news